Insider Sell‑Offs Signal BioLife’s Merger Exit—What It Means for Investors
Inside the BioLife‑Repligen merger: key insider trades, 53,156 shares sold by Goswami Joydeep, and how the deal reshapes shareholder value.
4 minutes to read
BIOLIFE SOLUTIONS INC
BioLife Insider Sales Surge Ahead of Repligen Merger: What Investors Must Know
BioLife Insider sales surge ahead of Repligen merger. Explore why execs are selling and what it means for investors.
3 minutes to read